Sustained use of oxymetazoline cream efficacious for rosacea

May 18, 2018

(HealthDay)—Oxymetazoline is safe and effective for the treatment of moderate-to-severe persistent erythema of rosacea, according to a study published in the June issue of the Journal of the American Academy of Dermatology.

Zoe Diana Draelos, M.D., from Dermatology Consulting Services in High Point, Tenn., and colleagues examined the long-term safety (one year) and efficacy of oxymetazoline cream 1.0 percent in 440 patients with with moderate-to-severe persistent facial erythema. Assessments were conducted at three and six hours after the dose on day one, and at weeks four, 26, and 52.

The researchers found that 8.2 percent of patients reported treatment-emergent adverse events (TEAEs), the most common were application site dermatitis, paresthesia, pain, and pruritus. The rate of discontinuation mostly due to application-site TEAEs was 3.2 percent. There was no clinically meaningful skin blanching, , or telangiectasia. At week 52, a 2-grade or greater composite improvement from baseline in both Clinician Erythema Assessment and Subject Self-Assessment three and six hours after a dose was seen in 36.7 and 43.4 percent of patients, respectively. Following treatment cessation, less than 1 percent of experienced a rebound effect.

"This long-term study demonstrated sustained safety, tolerability, and efficacy of oxymetazoline for moderate-to-severe persistent erythema of rosacea," the authors write.

Several authors disclosed financial ties to Allergan, which is a manufacturer of oxymetazoline and funded the study.

Explore further: Newly designed pulsed-dye laser found effective for rosacea

More information: Abstract/Full Text

Related Stories

Newly designed pulsed-dye laser found effective for rosacea

April 20, 2018
(HealthDay)—A pulsed-dye laser with a novel 15-mm diameter treatment beam improves the appearance of rosacea, according to a study published online April 10 in Lasers in Surgery and Medicine.

Crisaborole safe for long-term treatment of atopic dermatitis

October 11, 2017
(HealthDay)—Crisaborole ointment appears to be safe for the long-term treatment of atopic dermatitis (AD), according to a study published in the October issue of the Journal of the American Academy of Dermatology.

New formulated moisturizer effective for facial dermatitis

February 24, 2018
(HealthDay)—Facial moisturizers with specific ingredients may be effective for treating mild-to-moderate dermatitis, according to a study published online Feb. 6 in the Journal of Cosmetic Dermatology.

For rosacea, ivermectin offers lasting improvement in HRQoL

April 14, 2016
(HealthDay)—For patients with rosacea, ivermectin treatment is associated with long-term improvement in health-related quality of life (HRQoL), according to a study published online April 8 in the British Journal of Dermatology.

Serlopitant found to be safe, effective for chronic pruritus

April 24, 2018
(HealthDay)—Serlopitant has potential as a therapy for the treatment of chronic pruritus, according to a study published in the May issue of the Journal of the American Academy of Dermatology.

Ivermectin tops metronidazole for papulopustular rosacea

April 7, 2015
(HealthDay)—For patients with papulopustular rosacea (PPR), once-daily ivermectin 1 percent cream (IVM 1 percent) is superior to twice-daily metronidazole (MTZ 0.75 percent) cream, according to a study published in the ...

Recommended for you

New hope for cystic fibrosis

October 19, 2018
A new triple-combination drug treatment being trialled at the Mater Hospital in Brisbane could increase the life expectancy of patients with cystic fibrosis.

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.